Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML-335 is a μ-δ isomer-targeted agonist, a μOR-δOR-biased ligand that can serve as a scaffold for the development of unique types of (isomer-biased) drugs.ML-335 is a MOR (μ-opioid receptor)/DOR (δ-opioid receptor) heterodimer, with anti-injury sensory activity and pain inhibitory activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 93.00 | |
10 mg | In stock | $ 148.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 463.00 | |
100 mg | In stock | $ 668.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | ML-335 is a μ-δ isomer-targeted agonist, a μOR-δOR-biased ligand that can serve as a scaffold for the development of unique types of (isomer-biased) drugs.ML-335 is a MOR (μ-opioid receptor)/DOR (δ-opioid receptor) heterodimer, with anti-injury sensory activity and pain inhibitory activity. |
Targets&IC50 | μ opioid receptor:0.125 µM(EC50) |
In vivo | CYM51010 (ML-335) (subcutaneous injection; SNL rats) inhibited mechanical hypersensitivity in a dose-related manner (EC50: 1.09 mg/kg) and also reversed heat hyperalgesia and attenuated ongoing pain (2 mg/kg, subcutaneously)[1]. |
Molecular Weight | 408.53 |
Formula | C25H32N2O3 |
CAS No. | 1069498-96-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9.0 mg/mL (22.1 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML-335 1069498-96-9 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor ML335 ML 335 inhibitor inhibit